NCT03281278已完成不适用
A Prospective Study of Application of Platelet Mapping in HBV-related Acute-on-chronic-liver Failure in China
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- 28-day mortality
研究概览
简要总结
Ineffective hemostasis or a paradoxical prothrombotic state of Acute-on-chronic liver disease (ACLF) has been well established. Thrombelastography measures the dynamics of thrombin production and provides a global assessment of coagulation incorporating the cumulative effect of the interactions at various levels between plasma components and cellular component of coagulation. And through the platelet mapping, it can help provide a picture of patients' function of platelet. This study aims to explore the predictive role of platelet mapping in ACLF prognosis, organ failure developments and short term mortality.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patient with previously diagnosed or undiagnosed HBV related chronic liver disease/cirrhosis
- •INR≥1.5 and total bilirubin≥85μmol/L
排除标准
- •INR≤1.5 or total bilirubin≤85μmol/L;
- •underlying chronic liver disease was other than chronic HBV infection related;
- •those who had hepatocellular carcinoma or other types of malignancies;
- •obstructive biliary diseases or other disease lead to bilirubin evaluation;
- •those who had acute hemorrhage one week before admission
- •those who received platelet, cryo transfusion or plasmapheresis one week before admission
- •using steroid or immunosuppressant or antiplatelet or anticoagulant drugs in 4 weeks
- •any kind of decompensation which persisted over a month
- •pregnancy and breastfeeding
- •those who received liver transplantation or kidney transplantation;
- •combine with other disease lead to organ failure including heart failure (NYHA IV),respiratory failure（PaO2<60mmHg),renal insufficiency(CKD 5) and conscious disturbance (GCS<8)
- •readmission;
- •death within 24 hours.
结局指标
主要结局
28-day mortality
时间窗: 28-day
death within 28-day
次要结局
- 90-day mortality(90-day)
- 28-day progression(28-day)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Prospective Study of Application of Platelet Mapping in Chronic Liver Disease Complicated With ALI and/or AD in ChinaThrombelastography, Acute Liver Injury, Acute Decompensation, PlateletNCT04675125Nanfang Hospital, Southern Medical University200
Unknown
不适用
A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in ChinaLiver Failure, Acute on ChronicHemostatic DisorderNCT03281252Nanfang Hospital, Southern Medical University100
已完成
不适用
A Multicenter Prospective Study of Application of Platelet Mapping in Acute-on-chronic-liver Failure in ChinaMulticenter Prospective StudyThrombelastographyPlateletAcute on Chronic Liver FailureNCT04119973Nanfang Hospital, Southern Medical University486
Unknown
4 期
Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using ThromboelastographyCirrhosisAcute on Chronic Liver FailureNCT02757170All India Institute of Medical Sciences, New Delhi180
Unknown
不适用
Platelet Transfusion in Acute-on Chronic Liver FailureAcute-On-Chronic Liver FailureNCT04564651Nanfang Hospital, Southern Medical University80